Free provider profile
RICK TRAUTNER, M.D.
NPI 1841395266
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2007-07-08.
2006 DWIGHT WAY STE 302, BERKELEY, CA, 94704
510-649-1592
Single practice location
Enumerated 2006-09-13
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 1 payer identifiers on file — enrolled with payers.
- — Record last updated 19 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
316
Medicare patients
31
Part D drug cost
$63,066
Brand-name share
11.4%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Spravato (Esketamine Hcl) | 28 | $33,580 |
| Lamotrigine (Lamotrigine) | 32 | $791 |
| Trazodone Hcl (Trazodone Hcl) | 24 | $627 |
| Mirtazapine (Mirtazapine) | 15 | $468 |
| Clonazepam (Clonazepam) | 26 | $441 |
| Risperidone (Risperidone) | 11 | $384 |
| Escitalopram Oxalate (Escitalopram Oxalate) | 23 | $370 |
| Quetiapine Fumarate (Quetiapine Fumarate) | 11 | $242 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
202443 sessions · 11 patients · $56,461
202366 sessions · 17 patients · $82,959
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.